Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q3 2015 · 10-Q
Revenue$5.15B$5.15B+1.4% vs Q3 2014 Net Income$580.00M$580.00M+7.8% vs Q3 2014 EPS Diluted$0.38$0.38+5.6% vs Q3 2014 Gross Profit$2,757,000,000+4.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,195,000,000−0.5% Free Cash Flowderived$784,000,000−15.2% Margins · derivedGross margin53.5%+1.8 pt vs Q3 2014
Operating margin13.8%−0.5 pt vs Q3 2014
Net margin11.3%+0.7 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 5, 2015 · 36 d after period end